BI-1569912 is a selective negative allosteric modulator of NR2B-containing NMDA receptors. It is being developed by Boehringer Ingelheim to treat major depressive disorder.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.